Taken together, the findings suggest that LRRFIP1 may influence cell proliferation and mobility in pancreatic cancer through regulation of AKT/GSK-3β/β-catenin signaling pathway. This evidence concerns the gene GSK3B and familial pancreatic carcinoma.